Quest Diagnostics (DGX)

• Market cap: $17.1B
• 1 day: 1.04%
• 5 days: -1.09%
• 1 month: -5.10%
• 3 months: 0.07%
• 6 months: 10.78%
• Year to date: 8.72%
• 1 year: 13.60%
• 5 years: 42.92%
• 10 years: 126.68%
• Sector: Healthcare
• Industry: Medical Laboratories

About: Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Employees: 48,000

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

10% more call options, than puts

Call options by funds: $62.2M | Put options by funds: $56.3M

10% more capital invested

Capital invested by funds: $13.6B [Q2] → $14.9B (+$1.35B) [Q3]

4% more first-time investments, than exits

New positions opened: 93 | Existing positions closed: 89

0% more funds holding

Funds holding: 824 [Q2] → 828 (+4) [Q3]

4% less repeat investments, than reductions

Existing positions increased: 287 | Existing positions reduced: 300

2.43% less ownership

Funds ownership: 89.08% [Q2] → 86.66% (-2.43%) [Q3]

50% less funds holding in top 10

Funds holding in top 10: 4 [Q2] → 2 (-2) [Q3]

Research analyst outlook

10 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $165 8% upside
• Avg. target: $174 14% upside
• High target: $185 21% upside

10 analyst ratings

• positive: 6 60%
• neutral: 4 40%
• negative: 0 0%

Morgan Stanley Erin Wright 48% 1-year accuracy 11 / 23 met price target	12% upside $172	Overweight Upgraded	17 Dec 2024
B of A Securities Derik De Bruin 32% 1-year accuracy 6 / 19 met price target	19% upside $182	Buy Maintained	13 Dec 2024
Jefferies Tycho Peterson 50% 1-year accuracy 6 / 12 met price target	21% upside $185	Buy Assumed	10 Dec 2024
Piper Sandler David Westenberg 69% 1-year accuracy 27 / 39 met price target	8% upside $165	Neutral Maintained	28 Oct 2024
Mizuho Ann Hynes 41% 1-year accuracy 9 / 22 met price target	14% upside $174	Outperform Maintained	24 Oct 2024